FcγRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patients

被引:32
作者
Yun, HR
Koh, HK
Kim, SS
Chung, WT
Kim, DW
Hong, KP
Song, GG
Chang, HK
Choe, JY
Bae, SC
Salmon, JE
Yoo, DH [1 ]
Kim, TY
Kim, SY
机构
[1] Hanyang Univ, Hosp Rheumat Dis, Div Rheumatol, Seoul 133792, South Korea
[2] Chosun Univ, Div Rheumatol, Kwangju 501759, South Korea
[3] Dong A Univ, Div Rheumatol, Pusan, South Korea
[4] Inje Univ, Div Rheumatol, Pusan, South Korea
[5] Koshin Univ, Div Rheumatol, Pusan, South Korea
[6] Korea Univ, Div Rheumatol, Seoul 136701, South Korea
[7] Univ Ulsan, Dept Rheumatol, Kangnung, South Korea
[8] Catholic Univ, Div Rheumatol, Taegu, South Korea
[9] Hosp Special Surg, Div Rheumatol, New York, NY 10021 USA
[10] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[11] Hanyang Univ, Hosp Rheumat Dis, Div Diagnost Immunol, Seoul 133791, South Korea
关键词
SLE; clinical manifestation; Fc gamma receptor; polymorphism; gender;
D O I
10.1191/096120301678416015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to determine the distribution of the Fc gamma RIIa and Fc gamma RIIIa polymorphisms and their association with clinical manifestations in Korean lupus patients. Three hundred SLE (systemic lupus erythematosus) patients (48 male, 252 female) meeting 1982 ACR criteria and 197 Korean disease-free controls were enrolled. Genotyping for Fc gamma RIIa 131 R/H and Fc gamma RIIIa 176 F/V was performed by PCR of genomic DNA using allele-specific primers and the Fc gamma RIIIa genotype was confirmed by direct sequencing of PCR product in some cases. There was significant skewing in the distribution of the three Fc gamma RIIa genotypes between the SLE and the controls (P = 0.002 for R/R131 vs R/H131 and H/H131, OR 2.5 (95% CI 1.4-4.5), but not in Fc gamma RIIIa genotypes. Fc gamma RIIa-R allele was a significant predictor of lupus nephritis, as compared with SLE patients without nephritis (P = 0.034 for R131 vs H131, OR 1.4 (95% CI 1.03-1.9)), but proliferative nephritis (WHO class III and IV) was less common in patients with Fc gamma RIIa-R/R131 and in Fc gamma RIIa-R allele. In 300 SLE patients, high binding allele combination H131/V176 was less common in SLE with nephritis than in SLE without nephritis. Hemolytic anemia was less common in R131/F176 allele combination among four Fc gamma RIIa/Fc gamma RIIIa allelic combinations. Male SLE patients showed a higher frequency of renal involvement, serositis, thrombocytopenia, malar rash and discoid rash than female SLE, and male SLE had a higher frequency of Fc gamma RIIa-R/R131 or R131-allele than male controls, but Fc gamma RIIa or Fc gamma RIIIa genotypes had no association with renal involvement in male SLE patients. Fc gamma RIIa-H/H131 showed a higher frequency of hemolytic anemia and less pulmonary complications in male SLE. Female SLE patients showed higher frequency of any hematologic abnormality, lymphopenia, anticardiolipin antibody (+) and anti-Re antibody (+) than male SLE, and had earlier onset of first symptoms. There was no skewing in Fc gamma RIIa or Fc gamma RIIIa genotypes between female SLE and female controls, but Fc gamma RIIa-R131 allele showed skewing between female SLE with nephritis and female SLE without nephritis. The age at onset of thrombocytopenia was earlier in Fc gamma RIIa-R/R131 among three Fc gamma RIIa genotypes, and serositis in Fc gamma RIIIa-F/F176 among three Fc gamma RIIIa genotypes. Fc gamma RIIa-R131 homozygote was a major predisposing factor to the development of SLE and Fc gamma RIIa-R131 homozygote and R131 allele were a predisposing factor, and H131/V176 was a protective allele combination in lupus nephritis. In contrast to other ethnic patients, in our study cohort, clinical manifestation was different between male and female, and Fc gamma RIIa and Fc gamma RIIIa showed somewhat different clinical associations between the genders.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 39 条
[1]  
AHMED SA, 1985, AM J PATHOL, V121, P531
[2]  
ARNETT FC, 1992, RHEUM DIS CLIN N AM, V18, P865
[3]  
BLUM A, 1991, CLIN EXP RHEUMATOL, V9, P206
[4]  
BOTTO M, 1996, CLIN EXP IMMUNOL, V104, P265
[5]   CELLULAR SIGNALS FOR THE INDUCTION OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
CHANG, DM .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 74 (01) :23-30
[6]   Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections [J].
deVries, E ;
Koene, HR ;
Vossen, JM ;
Gratama, JW ;
vondemBorne, AEGK ;
Waaijer, JLM ;
Haraldsson, A ;
deHaas, M ;
vanTol, MJD .
BLOOD, 1996, 88 (08) :3022-3027
[7]  
DUITS AJ, 1995, ARTHRITIS RHEUM, V39, P1832
[8]   A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families [J].
Gaffney, PM ;
Kearns, GM ;
Shark, KB ;
Ortmann, WA ;
Selby, SA ;
Malmgren, ML ;
Rohlf, KE ;
Ockenden, TC ;
Messner, RP ;
King, RA ;
Rich, SS ;
Behrens, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14875-14879
[9]   SYSTEMIC LUPUS-ERYTHEMATOSUS - A REVIEW OF CLINICO-LABORATORY FEATURES AND IMMUNOGENETIC MARKERS IN 150 PATIENTS WITH EMPHASIS ON DEMOGRAPHIC SUBSETS [J].
HOCHBERG, MC ;
BOYD, RE ;
AHEARN, JM ;
ARNETT, FC ;
BIAS, WB ;
PROVOST, TT ;
STEVENS, MB .
MEDICINE, 1985, 64 (05) :285-295
[10]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725